Acrivon Therapeutics, Inc.·4

Jan 22, 4:15 PM ET

Miller Mary 4

4 · Acrivon Therapeutics, Inc. · Filed Jan 22, 2025

Insider Transaction Report

Form 4
Period: 2025-01-17
Miller Mary
Chief Legal Officer
Transactions
  • Tax Payment

    Common Stock

    2025-01-17$5.78/sh659$3,80937,282 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file
  • 4
    form4.xmlPrimary